Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2019, ended Jan 31, 2019 | — |
| FY2020, ended Jan 31, 2020 | — |
| FY2021, ended Jan 31, 2021 | $78.7B |
| FY2022, ended Jan 31, 2022 | $86.8B |
| FY2023, ended Jan 31, 2023 | $50.8B |
| FY2024, ended Jan 31, 2024 | $65.4B |
| FY2025, ended Jan 31, 2025 | $60.6B |
| FY2026, ended Jan 31, 2026 | $66.6B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $103B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2019, ended Jan 31, 2019 | $96.7M |
| FY2020, ended Jan 31, 2020 | $265M |
| FY2021, ended Jan 31, 2021 | $592M |
| FY2022, ended Jan 31, 2022 | $1.22B |
| FY2023, ended Jan 31, 2023 | $2.07B |
| FY2024, ended Jan 31, 2024 | $2.81B |
| FY2025, ended Jan 31, 2025 | $3.63B |
| FY2026, ended Jan 31, 2026 | $4.68B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $5.43B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2019, ended Jan 31, 2019 | −$178M | −$146M |
| FY2020, ended Jan 31, 2020 | −$349M | −$195M |
| FY2021, ended Jan 31, 2021 | −$539M | −$80.5M |
| FY2022, ended Jan 31, 2022 | −$680M | $94.0M |
| FY2023, ended Jan 31, 2023 | −$797M | $521M |
| FY2024, ended Jan 31, 2024 | −$836M | $813M |
| FY2025, ended Jan 31, 2025 | −$1.29B | $913M |
| FY2026, ended Jan 31, 2026 | −$1.33B | $1.12B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | −$1.09B | $1.20B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2019, ended Jan 31, 2019 | $117M |
| FY2020, ended Jan 31, 2020 | $127M |
| FY2021, ended Jan 31, 2021 | $820M |
| FY2022, ended Jan 31, 2022 | $1.09B |
| FY2023, ended Jan 31, 2023 | $940M |
| FY2024, ended Jan 31, 2024 | $1.76B |
| FY2025, ended Jan 31, 2025 | $2.63B |
| FY2026, ended Jan 31, 2026 | $2.83B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $1.71B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2019, ended Jan 31, 2019 | — |
| FY2020, ended Jan 31, 2020 | — |
| FY2021, ended Jan 31, 2021 | — |
| FY2022, ended Jan 31, 2022 | — |
| FY2023, ended Jan 31, 2023 | — |
| FY2024, ended Jan 31, 2024 | $0 |
| FY2025, ended Jan 31, 2025 | $2.27B |
| FY2026, ended Jan 31, 2026 | $2.28B |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $2.28B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Up 824% since FY19.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2019, ended Jan 31, 2019 | 38.2M |
| FY2020, ended Jan 31, 2020 | 44.8M |
| FY2021, ended Jan 31, 2021 | 289M |
| FY2022, ended Jan 31, 2022 | 315M |
| FY2023, ended Jan 31, 2023 | 325M |
| FY2024, ended Jan 31, 2024 | 334M |
| FY2025, ended Jan 31, 2025 | 334M |
| FY2026, ended Jan 31, 2026 | 346M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | 353M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2019, ended Jan 31, 2019 | $29.6M | $22.4M | $0 | — |
| FY2020, ended Jan 31, 2020 | $0 | $78.4M | $0 | $4.75M |
| FY2021, ended Jan 31, 2021 | $0 | $301M | $4.24B | — |
| FY2022, ended Jan 31, 2022 | $0 | $605M | $0 | — |
| FY2023, ended Jan 31, 2023 | $0 | $862M | $0 | $439M |
| FY2024, ended Jan 31, 2024 | $592M | $1.17B | — | $174M |
| FY2025, ended Jan 31, 2025 | $1.93B | $1.48B | — | $87.7M |
| FY2026, ended Jan 31, 2026 | $874M | $1.60B | — | $13.1M |
| Trailing 12 months to Jul 31, 2026 (through Q2 FY2027) | $683M | $1.64B | — | — |
Valuation
At current price- Market Cap
- $119B
- P/E
- n/m. Market cap / net income (TTM)
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 21.9×
- Price / Book
- 55.4×
- EV / EBITDA
- n/m. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $5.43B
- Revenue Growth YoY
- 32.0%
- Revenue CAGR 3Y
- 31.4%
- Revenue CAGR 5Y
- 51.2%
- EPS Growth YoY
- n/m. Diluted EPS, TTM vs. TTM a year earlier
- Net Income Growth YoY
- n/m. TTM vs. TTM a year earlier
Profitability
Trailing 12 months- Gross Margin
- 67.0%
- Operating Margin
- −22.8%
- Net Margin
- −20.1%
- FCF Margin
- 22.0%
- Return on Equity
- −48.2%
Earnings
Trailing 12 months- Net Income
- −$1.09B
- EPS (diluted)
- −$3.17
- EBITDA
- −$984M
- Operating Income
- −$1.24B
Balance Sheet
As of Jul 31, 2026- Cash and cash equivalents
- $1.71B
- Total Debt
- $2.28B
- Net Debt
- $577M
- Total Assets
- $8.69B
- Total Liabilities
- $6.54B
- Shareholders' Equity
- $2.15B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $1.25B
- Capital Expenditure
- $58.0M
- Free Cash Flow
- $1.20B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.35
Every ratio is calculated from the company’s reported figures.